Pieris Pharmaceuticals Inc - PIRS Earnings per share for the trailing year

Pieris Pharmaceuticals Inc (PIRS) - corporate logo

Pieris Pharmaceuticals (PIRS) develops proteins to combat tumors and lung pathologies, yet a lack of recurring revenue leaves the company dependent on test results. The development of new drugs is accelerating through strategic alliances and the Anticalin platform. Management is currently cutting ancillary projects to preserve assets. The trailing twelve months (ttm) earnings per share growth rate exhibits sideways movement, with the latest reading at 55.90.

pieris.com (PIRS): Earnings per share for the last twelve months from 02/11/2024 to 11/17/2026

pieris.com - analytical breakdowns and key metrics (PIRS)

- issuer market value details:
Fundamental company valuation:PIRS, Pieris Pharmaceuticals Inc
Brand item of Pieris Pharmaceuticals

Pieris Pharmaceuticals (PIRS) develops high-precision anticalin platforms to combat cancer and lung pathologies. This chart of annual EPS TTM growth illustrates the net profit per share dynamics over a twelve-month period. The metric calculates the percentage change in earnings, allowing investors to filter out market noise from the sustainable trend. The steady growth of the line confirms the effective capitalization of scientific research. For the investor, this indicator serves as a marker of the real return on investment in biomedical innovations.

Competitor analysis

Earnings per share for the trailing year HLN (Haleon)|KVUE: Net earnings per share (EPS TTM)|Verona Pharma Corp - Earnings per share for the trailing year|MENS (Jyong Biotech Limited) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ligand.com LGND|Earnings per share for the last twelve months Amneal (AMRX)|PRGO (Perrigo Company PLC) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALVO (Alvotech S.A.)|Liquidia Technologies - Earnings per share for the last twelve months|Galapagos Corp - Net earnings per share (EPS TTM)|ANIP (ANI Pharmaceuticals) - Earnings per share for the last 12 months|MannKind Corp. (MNKD) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Corp) - Net earnings per share (EPS TTM)|SPRY: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TBPH|Net earnings per share for the last four quarters Aquestive Therapeutics, Inc.|Earnings per share for the last twelve months scPharmaceuticals Inc. SCPH|TECX: Earnings per share for the last 12 months|TNXP - Earnings per share for the last twelve months|Net earnings per share for the last four quarters SXT Pharmaceuticals SXTC|EPRX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months bioharvest.com (BHST)|Net earnings per share for the last 12 months EXOZ|ORMP: Earnings per share for the trailing year|Earnings per share for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC (ABVC BioPharma, Inc)|Earnings per share for the trailing year CPIX|QNTM - Earnings per share for the last twelve months|FibroGen Corp (FGEN) - Net earnings per share for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Earnings per share for the last twelve months|Rani Therapeutics (RANI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Synergy CHC Corp.|Net earnings per one share for the last twelve months rallybio.com RLYB|Net earnings per share (EPS TTM) LEXX|PULM: Earnings per one share for the last 12 months|Pheton Holdings Ltd - Net earnings per share for the last 12 months|APM - Net earnings per share for the last 12 months|LYRA - Earnings per share for the last twelve months|Earnings per share for the trailing year IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Earnings per share for the last twelve months|cbdMD Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) LIPO|Net earnings per share (EPS TTM) optinose.com (OPTN)|Earnings per share for the last twelve months Procaps Group Corp PROC|Petros Pharmaceuticals Inc - Earnings per share for the last twelve months|Qilian International Corp - Net earnings per share (EPS TTM)|ACELYRIN, Inc. (SLRN) - Net earnings per share for the last 12 months|TFF Pharma (TFFP) - Earnings per share for the last twelve months